This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,074.90, is for the delivery of Pioglitazone HCL 45 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,669.15, is a Firm Fixed Price Delivery Order for the supply of Pioglitazone HCL 45 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,899.44 firm-fixed-price delivery order is for the supply of 500 tablets of 30 mg Pioglitazone HCl, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,810.23, is a firm fixed-price delivery order for the supply of pioglitazone HCL 30 mg tablets. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the provision of 4565110842 Pioglitazone HCL 30 MG Tablet 500s. The $1,939.96 fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 11, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,222.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a broader Indefinite Delivery Contract (IDC) with the DLA, is for the supply of 4566832860 Pioglitazone HCL 30 mg tablets. The IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,698.25 firm fixed-price delivery order is for the supply of Pioglitazone HCL 45 mg tablets, a medication used to treat type 2 diabetes. This contract is not designated as a set-aside requirement. The award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen...
This federal contract award, valued at $1,191.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, covers the provision of Pioglitazone HCL 15 mg tablets. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,375.08, is for the delivery of pioglitazone HCL 30 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,170.32, is for the delivery of 500 tablets of Pioglitazone HCL 30 mg, a medication used to treat type 2 diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora,...